Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.

Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, Lu W, Wei Q, Ye J, Cai X, Hu C, Yin X, Cao P. · 2019

Read Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. by Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, Lu W, Wei Q, Ye J, Cai X, Hu C, Yin X, Cao P. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6882204.txt.

Introduction

Cao and co-authors report a study in the Journal for ImmunoTherapy of Cancer on particles from ginseng. The root Panax ginseng has a long medicinal history. Plants shed extracellular vesicles, and whether such particles can speak to animal cells was unclear. The team isolated ginseng-derived nanoparticles and tested them on macrophages inside tumours.

Tumour macrophages often sit in a supportive state, M2, that helps cancer grow and spread. The ginseng particles pushed them toward the tumour-fighting M1 state, in dishes and in mice. Treated macrophages also lost their power to suppress killer T cells. Melanoma growth slowed as a result. The authors propose plant particles as an unlikely ally for cancer immunotherapy.

Catalog record

CREATORCao M, Yan H, Han X, Weng L, Wei Q, Sun X, Lu W, Wei Q, Ye J, Cai X, Hu C, Yin X, Cao P.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE74 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6882204

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth By Meng Cao, Huaijiang Yan, Xuan Han, Ling Weng, Qin Wei, Xiaoyan Sun, Wuguang Lu, Qingyun Wei, Juan Ye, Xueting Cai, Chunping Hu, Xiaoyang Yin Published in: Journal for Immunotherapy of Cancer DOI: 10.1186/s40425-019-0817-4 ABSTRACT Abstract Background It is unclear whether plant-derived extracellular vesicles (EVs) can mediate interspecies communication with mammalian cells. Tumor-associated macrophages (TAMs) display a continuum of different polarization states between tumoricidal M1 phenotype and tumor-supportive M2 phenotypes, with a lower M1/M2 ratio correlating with tumor growth, angiogenesis and invasion. We investigated whether EVs from ginseng can alter M2-like polarization both in vitro and in vivo to promote cancer immunotherapy. Methods A novel EVs-liked ginseng-derived nanoparticles (GDNPs) were isolated and characterized from Panax ginseng C. A. Mey. Using GDNPs as an immunopotentiator for altering M2 polarized macrophages, we analyzed associated surface markers, genes and cytokines of macrophages treated with GDNPs. Mice bearing B16F10 melanoma were treated with GDNPs therapy. Tumor growth were assessed, and TAM populations were evaluated by FACS and IF. Results GDNPs significantly promoted the polarization of M2 to M1 phenotype and produce total reactive oxygen species, resulting in increasing apoptosis of mouse melanoma cells. GDNP-induced M1 polarization was found to depend upon Toll-like receptor (TLR)-4 and myeloid differentiation antigen 88 (MyD88)-mediated signaling. Moreover, ceramide lipids and proteins of GDNPs may play an important role in macrophage polarization via TLR4 activation. We found that GDNPs treatment significantly suppressed melanoma growth in tumor-bearing mice with increased presence of M1 macrophages detected in the tumor tissue. Conclusions GDNPs can alter M2 polarization both in vitro and in vivo, which contributes to an antitumor response. The polarization of macrophages induced by GDNPs is largely dependent on TLR4 and MyD88 signalling. GDNPs as an immunomodulator participate in mammalian immune response and may represent a new class of nano-drugs in cancer immunotherapy. Keywords: Extracellular vesicles (EVs), Ginseng-derived nanoparticles, Tumor-associated macrophages (TAM), Macrophage polarization, Melanoma BACKGROUND The root of Panax ginseng C.A. Mey (Araliaceae) is well known for its multiple pharmacological properties, including anticancer, anti-inflammatory, antioxidant, and aging inhibitory effects [1–3]. Several studies have reported the immune-enhancing properties of ginseng root extract for cancer treatment, but the effector mechanism of their immunomodulating activity has remained partially understood [4, 5]. Extracellular vesicles (EVs) are nano-sized membrane vesicles with a cargo that includes diverse proteins, lipids, nucleic acids and polysaccharides [6, 7]. Cellular studies have shown that EVs bear surface receptors and ligands of the original cells and mediate intercellular communication [8]. In the past decade, the ability of mammalian EVs to transport bioactive contents has stimulated research into their biology and the development of EV-based therapies and diagnostic tests [9]. Like mammalian cells, plant cells also secrete EVs, although very little is known about their origins, compositions or functions [10]. Recent studies have indicated that these plant-derived nanoparticle-like EVs may be involved in plant cell–cell communication as a means to regulate plant innate immunity [11]. In addition, some plant-derived EVs may also mediate cross-species RNA interference causing fungal gene silencing [12]. It has never been reported previously whether ginseng release nanoparticle-like EVs, let alone the physiological function of plant-derived EVs in mammalian cells. Macrophages are a major part of the mononuclear phagocyte system (MPS), which is responsible for the clearance for foreign matter from the body [13]. As a consequence, nanoparticles that come into contact with macrophages will be rapidly recognized, internalized, and degraded. This intrinsic mechanism of vesicle uptake by macrophages may be employed to target these cells for nanotherapeutic formulation [14]. There is recent evidence that natural and modified EVs from mammalian cells can induce an antitumor response in macrophages to inhibit tumor growth [15, 16]. Tumor-associated macrophages (TAMs) are a major component of the tumor microenvironment (TME) [17]. TAM infiltration in tumor tissues has been shown to support tumor growth, angiogenesis, invasion and metastasis, and a high density of TAMs in tumors is correlated with tumor progression and drug resistance. Thus, TAMs have been regarded as promising targets for novel anticancer agents [18]. In general, TAMs are considerably plastic and assume opposing phenotypes and functions, including tumoricidal M1 and tumor-supportive M2 macrophages. In most tumor types, macrophages with M2-like phenotype prevail. Thus, both depletion of M2-like cells and skewing the M1/M2 ratio towards M1-like phenotype have emerged as attractive therapeutic strategies in the treatment of cancer [19, 20]. Here, we successfully isolated and purified nanoparticle-like EVs efficiently from the roots of Panax ginseng C. A. Mey. Component analyses of these ginseng-derived nanoparticles (GDNPs) revealed that they are highly enriched in proteins, lipids and nucleic acids. We show that GDNPs induce M1-like macrophage polarization via Toll-like receptor (TLR)-4/myeloid differentiation antigen 88 (MyD88) signalling pathway and enhance production of total reactive oxygen species (ROS) to induce apoptosis of mouse melanoma cells. As a monotherapy, the administration of GDNPs in melanoma allografted mice altered the functional orientation of TAMs towards an M1-like phenotype, leading to suppressed tumor growth in vivo. Our work shows for the first time that GDNPs exert an immunomodulatory effect on murine macrophages to inhibit tumor growth in mice and provides the basis for further use as nano-drugs for cancer immunotherapy. MATERIALS AND METHODS Ethics statement, mice and cell lines All human experimental protocols were approved by the Ethics Committee for Human Studies of Affiliated Hospital of Integrated Traditional Chinese and Western Medicine (2018LWKYZ010). Wild-type (WT) C57BL/6 mice were purchased from the Comparative Medicine Center, Yangzhou University (Yangzhou, Jiangsu, China). MyD88-, TLR4- and TLR2-deficient C57/BL6 mice were gifts from Dr. Lixin Wang (Department of Microbiology and Immunology, Medical School of Southeast University, Nanjing, China) [21]. All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Nanjing University of Chinese Medicine. The murine melanoma cell line (B16F10), breast cancer cell line (4T1) and human embryonic kidney cell line (HEK293T) were purchased from the Institute of Biochemistry and Cell Biology, Academy of Science (Shanghai, China). Cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) or RPMI 1640, supplemented with 10% foetal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin (all from Thermo Fisher Scientific, USA). All cells were incubated at 37 °C in a humidified atmosphere with 5% CO2. Purification and characterization of GDNPs For isolation of GDNPs, fresh ginseng roots were purchased from Panax ginseng Base (Wanshan, Jilin, China) and washed with deionized water three times at room temperature (20 °C). After the final wash, ginseng roots were ground in a slow juicer to obtain ginseng fluid. Then, the juice was sequentially centrifuged at 200×g for 10 min, 2000×g for 20 min and 10,000×g for 30 min to remove large particles and fibres. The final supernatant was ultracentrifuged at 100,000×g for 60 min (Beckman Optima XE-100, Beckman, USA), and the pellets were resuspended in PBS, transferred to a gradient sucrose solution (15, 30, 45 and 60%) and ultracentrifuged at 150,000×g for another 60 min. The band at the 45% sucrose layer was collected and defined as GDNPs according to TEM (transmission electron microscopy) examination [22]. Finally, the GDNPs were diluted in PBS and ultracentrifuged at 100,000×g for 60 min, then the pellets were resuspended in sterile PBS. The resuspension was filtered (0.45 μm) and used

Read the complete text